Exome Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Hold |
4,673
| – | – | 2.71% | 9 |
|
|
2025
Q1 | $3.86M | Sell |
4,673
-3,574
| -43% | -$2.95M | 3.43% | 8 |
|
|
2024
Q4 | $6.37M | Sell |
8,247
-2,200
| -21% | -$1.7M | 4.78% | 2 |
|
|
2024
Q3 | $9.26M | Buy |
10,447
+747
| +8% | +$662K | 6.26% | 1 |
|
|
2024
Q2 | $8.78M | Hold |
9,700
| – | – | 7.82% | 1 |
|
|
2024
Q1 | $7.55M | Hold |
9,700
| – | – | 6.46% | 1 |
|
|
2023
Q4 | $5.65M | Buy |
+9,700
| New | +$5.65M | 5.59% | 2 |
|